These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18030974)

  • 1. Heart failure and sudden cardiac death: causes and cures.
    Marks AR
    Harvey Lect; 2005-2006; 101():39-57. PubMed ID: 18030974
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Leaky' ryanodine receptors and sudden cardiac death.
    Brown DA; Cascio WE
    Cardiovasc Res; 2009 Dec; 84(3):343-4. PubMed ID: 19815562
    [No Abstract]   [Full Text] [Related]  

  • 3. Not all sudden death is the same.
    Allen PD
    Circ Res; 2003 Sep; 93(6):484-6. PubMed ID: 14500330
    [No Abstract]   [Full Text] [Related]  

  • 4. Life, sudden death, and intracellular calcium.
    Eisner DA; Venetucci LA; Trafford AW
    Circ Res; 2006 Aug; 99(3):223-4. PubMed ID: 16888244
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of abnormal sarcoplasmic reticulum calcium release in canine left-ventricular myocytes results in cellular alternans.
    Armoundas AA
    IEEE Trans Biomed Eng; 2009 Feb; 56(2):220-8. PubMed ID: 19272939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiomyopathies and sudden cardiac death caused by RyR2 mutations: are the channels the beginning and the end?
    Jóna I; Nánási PP
    Cardiovasc Res; 2006 Aug; 71(3):416-8. PubMed ID: 16828071
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac ryanodine receptor gene (hRyR2) mutation underlying catecholaminergic polymorphic ventricular tachycardia in a Chinese adolescent presenting with sudden cardiac arrest and cardiac syncope.
    Mok NS; Lam CW; Fong NC; Hui YW; Choi YC; Chan KY
    Chin Med J (Engl); 2006 Dec; 119(24):2129-33. PubMed ID: 17199967
    [No Abstract]   [Full Text] [Related]  

  • 8. Arrhythmias in heart failure: beyond sudden cardiac death.
    Stehlik J; Feldman DS
    Curr Opin Cardiol; 2013 May; 28(3):315-6. PubMed ID: 23549238
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing patients with "refractory" heart failure.
    Smith AL
    J Med Assoc Ga; 2001 Dec; 90(4):32-5. PubMed ID: 11845682
    [No Abstract]   [Full Text] [Related]  

  • 10. Defective ryanodine receptor interdomain interactions may contribute to intracellular Ca2+ leak: a novel therapeutic target in heart failure.
    Lehnart SE; Wehrens XH; Marks AR
    Circulation; 2005 Jun; 111(25):3342-6. PubMed ID: 15983258
    [No Abstract]   [Full Text] [Related]  

  • 11. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
    Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K
    Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hatter Institute Cardiac Horizons series.
    Hitseroth J; Hendricks N
    Cardiovasc J Afr; 2008; 19(6):321-3. PubMed ID: 19104729
    [No Abstract]   [Full Text] [Related]  

  • 13. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
    Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
    Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoplasmic reticulum Ca2+ measurements reveal that the cardiac ryanodine receptor mutations linked to cardiac arrhythmia and sudden death alter the threshold for store-overload-induced Ca2+ release.
    Jones PP; Jiang D; Bolstad J; Hunt DJ; Zhang L; Demaurex N; Chen SR
    Biochem J; 2008 May; 412(1):171-8. PubMed ID: 18092949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defibrillation threshold testing in implantable cardioverter-defibrillators: might less be more than enough?
    Curtis AB
    J Am Coll Cardiol; 2008 Aug; 52(7):557-8. PubMed ID: 18687250
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management of chronic heart failure].
    Hogye M
    Orv Hetil; 2005 May; 146(19):975-7. PubMed ID: 15969311
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy.
    Bestetti RB; Theodoropoulos TA; Cardinalli-Neto A; Cury PM
    Am Heart J; 2008 Sep; 156(3):422-30. PubMed ID: 18760121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely.
    Tung R; Swerdlow CD
    Circulation; 2009 Sep; 120(10):825-7. PubMed ID: 19704090
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardiac resynchronization therapy and reduction of mortality in heart failure: a proven association].
    Mele D; Toselli T; Pratola C; Artale P; Ferrari R
    G Ital Cardiol (Rome); 2007 Dec; 8(12):760-9. PubMed ID: 18085101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.